Millipore Reports Continued Progress Toward Sustainability

Millipore Reports Continued Progress Toward Sustainability

2009 Sustainability Report highlights significant reductions in global energy and water use, innovative new Design for Sustainability program

BILLERICA, Mass.--(BUSINESS WIRE)--May 10, 2010 - Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today released its second annual Sustainability Report, which discloses the company's environmental and social responsibility accomplishments and reaffirms its commitment to delivering on its ambitious sustainability goals.

"I am proud of the substantial progress we have made in making sustainability a core part of the way we do business," said Martin Madaus, Millipore Chairman, President and CEO. "In 2009, we built on our success over the past four years, taking further steps to reduce our consumption of non-renewable resources, eliminate waste and adopt behavioral changes that support long-term sustainability. Despite global economic uncertainty, we sustained our investment in reducing our carbon footprint, and we made substantial inroads in three critical areas: climate and energy, products and packaging, and employee engagement."

The Sustainability Report details a number of achievements in these areas: In 2009 Millipore reduced its total global energy consumption by six percent (11 percent over the past four years), and reduced its global water consumption by 12 percent (22 percent since 2006). In addition, over the past four years Millipore has decreased its total greenhouse gas emissions by 15 percent-close to its goal of 20-percent reductions from 2006 levels.

In 2009 Millipore also launched an innovative Design for Sustainability program, which is now being incorporated into the company's product development process.

"We are modifying our manufacturing processes in order to reduce energy and water consumption and find new uses for production materials that would otherwise become waste," noted Madaus. "We are also collaborating with customers on ways to minimize packaging and manage the environmental impact of products through their entire life cycle."

"Millipore is embedding sustainability principles and best practices throughout its entire supply chain," added David Newman, Millipore Senior Director, Global Sustainability. "We are empowering employees around the world at every stage of this effort, and they are responding with innovative ideas and solutions that are helping us reduce the impact of our operations on our environment.

"Millipore is also making it easier for employees to make sustainable choices in their own lives, through a number of innovative programs that provide incentives for purchasing hybrid vehicles, conducting home energy audits and installing solar panels," added Newman. "In 2009 many employees took advantage of these programs, and we are very proud of their contributions."

Other initiatives and accomplishments highlighted in Millipore's 2009 Sustainability Report include LEED (Leadership in Energy and Environmental Design) certification for two U.S. facilities, solar system installations at two major sites (Bedford, Massachusetts and Molsheim, France), and receipt of several awards, including the New England Clean Energy Council's Corporate Citizen of the Year.

The report meets the Global Reporting Initiative G3 Sustainability Guidelines (B+ application level).

For more information about sustainability at Millipore, and to download a PDF version of the 2009 Sustainability Report, please visit the company's sustainability web site: www.millipore.com/sustainability.

About Millipore

Millipore (NYSE: MIL) is a life science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,000 employees in 30 countries worldwide. For more information, please visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER®
Research. Development. Production.

Millipore Forward Looking Statement

The matters discussed herein, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

Potential risks and uncertainties that could affect Millipore's future operating results include, without limitation, failure to achieve design wins into our pharmaceutical and biotechnology customers' manufacturing design phase for a particular drug; delay, suspension or termination of a customer's volume production; lack of availability of raw materials or component products on a timely basis; regulatory delay in the approval of customers' therapeutics; limitations on cash flow available for operations and investment due to increased debt service obligations; the inability to establish and maintain necessary product and process quality levels; reduced demand for animal-derived cell culture products; the inability to realize the expected benefits of development, marketing, licensing and other alliances; competitive factors such as new membrane or chromatography technology; the inability to achieve anticipated cost benefits of our supply chain initiatives; risks relating to our concentration of principal manufacturing operations; the inability to utilize technology in current or planned products due to overriding rights by third parties; potential environmental liabilities; conditions in the economy in general and in the bioscience and bioprocess markets in particular; foreign exchange fluctuations; reduced private and government research funding; exposure to product liability claims; and difficulties inherent in transferring or outsourcing of manufacturing operations. Please refer to our filings with the SEC, including our most recent Annual Report on Form 10-K, for more information on these and other risks that could cause actual results to differ.